BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2429082)

  • 1. Effects of tiapamil, a new calcium channel blocker, on ambulatory intraarterial blood pressure and exercise-induced changes in blood pressure.
    Caruana M; Al-Khawaja I; Prince H; Raftery EB
    J Cardiovasc Pharmacol; 1986; 8(5):1074-7. PubMed ID: 2429082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of tiapamil in patients with mild to moderate essential hypertension.
    Lacourcière Y; Carrier M; Toal CB
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):166-70. PubMed ID: 2475708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of action of tiapamil in stable exercise induced angina.
    Maltz MB; Davies DW; Caplin JL; Camm AJ
    Eur J Clin Pharmacol; 1987; 32(4):339-42. PubMed ID: 3609110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of incremental doses of tiapamil on exercise performance in patients with chronic stable angina pectoris.
    O'Keefe JC; Maltz MB; Butrous GS; Camm AJ
    Eur Heart J; 1986 Oct; 7(10):843-7. PubMed ID: 3539614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
    Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of tiapamil and atenolol in patients with mild to moderate hypertension: a multicenter trial.
    Sykulski R; Keller N; Storm T; Stokke O; Myhre T; Himanen P; Quitzau K
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):427-31. PubMed ID: 2487539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a new calcium antagonist, tiapamil, in hypertension of the elderly.
    Balansard P; Elkik F; Levenson JA; Ciampi M; Sans P
    Br J Clin Pharmacol; 1984 Dec; 18(6):823-9. PubMed ID: 6529523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term hemodynamic effects of tiapamil at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1989 Aug; 3(4):517-23. PubMed ID: 2488103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjects.
    Laederach K; Weidmann P; Lauener F; Gerber A; Ziegler WH
    J Cardiovasc Pharmacol; 1986; 8(2):294-302. PubMed ID: 2422467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats.
    Hefti F; Gerold M; Holck M
    J Cardiovasc Pharmacol; 1984; 6(6):1192-200. PubMed ID: 6084779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic effects of tiapamil on exercise-induced arrhythmias in patients with coronary artery disease.
    Burkart F; Baitsch G; Braun S; Bertel O; Cocco G
    Cardiology; 1982; 69 Suppl():165-71. PubMed ID: 6758932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of calcium blockade by tiapamil in normal and hypertensive subjects.
    Ribstein J; Cristol JP; Elkik F; Mimran A
    J Hypertens Suppl; 1985 Dec; 3(3):S165-7. PubMed ID: 2856696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
    Saini RK; Fulmor IE; Antonaccio MJ
    J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tiapamil on myocardial performance in coronary artery disease.
    Braun S; Miller H; Terdiman R; Laniado S
    Cardiology; 1982; 69 Suppl():79-84. PubMed ID: 7151086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of tiapamil in essential hypertension.
    Ding YA; Shieh SM; Yang SP; Sung PK
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):339-43. PubMed ID: 2452928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.
    Gerold M; Eigenmann R; Haeusler G
    J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiapamil--a new calcium antagonist.
    Opie LH; Muller CA; Thandroyen FT; Lloyd EA; Mabin T; Commerford PJ; Eichler HG
    S Afr Med J; 1985 Jun; 67(22):881-3. PubMed ID: 3890216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute antianginal effect of tiapamil.
    Gasic S
    Cardiology; 1982; 69 Suppl():209-24. PubMed ID: 6758933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiapamil in the management of supraventricular arrhythmias occurring after acute myocardial infarction.
    Strozzi C; Sfrisi C; Leutenegger F; Padula A; Bulgarelli R
    Cardiology; 1982; 69 Suppl():187-91. PubMed ID: 7151079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term tiapamil treatment of patients with angina pectoris.
    Salorinne Y; Himberg JJ; Eskelinen E
    Clin Cardiol; 1983 Apr; 6(4):171-5. PubMed ID: 6404577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.